-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
Hepatitis C Virus (HCV)
CAS No. | Product Name | Inquiry |
---|---|---|
50924-49-7 |
MizoribineBredinin is a nucleoside antibiotic produced by Eupenicillum brefeldianum M-2166. It has anti-L-5178Y cell and anti-pox virus activity, not against bacteria and fungi, |
|
517-44-2 |
SENNIDINE BPurgative activity. |
|
548-61-8 |
Tris(4-aminophenyl)methaneTris(4-aminophenyl)methane is a weak hepatitis C virus (HCV) helicase inhibitor and a triphenylmethane dye. |
|
581772-30-7 |
2',5-Difluoro-2'-deoxycytidine2',5-Difluoro-2'-deoxycytidine has potent activity against HCV and toxicity to ribosomal RNA (rRNA). |
|
593960-11-3 |
PIK-93PIK-93 is a potent PI3K inhibitor. |
|
610753-87-2 |
KIN101KIN101 is a potent RNA viral inhibitor with IC50s of 2 μM, >5 μM for influenza virus and Dengue virus (DNV), respectively. |
|
632325-71-4 |
FilociclovirFilociclovir is a broad-spectrum anti-herpesvirus compound with good antiviral activity against cytomegalovirus (CMV), herpes simplex virus (HHV)-6 and HHV-8, with EC50 values ranging from 0.7 μM to 8 μM. |
|
640281-90-9 |
ValopicitabineValopicitabine is a nucleoside analogue and the orally bioavailable 2'-C-methylcytidine (NM107) prodrug, with anti-hepatitis C virus (HCV) activity. |
|
640725-71-9 |
Valopicitabine dihydrochlorideValopicitabine dihydrochloride is a nucleoside analogue and the orally bioavailable 2'-C-methylcytidine (NM107) prodrug, with anti-hepatitis C virus (HCV) activity. |
|
641-12-3 |
SENNIDINE ASennidin A-stimulated glucose incorporation was completely inhibited by wortmannin. Sennidin A did not induce tyrosine phosphorylation of insulin receptor (IR) and insulin receptor substrate-1 (IRS-1), but induced phosphorylation of Akt and glucose transporter 4 (GLUT4) translocation. Our results suggest that in rat adipocytes, sennidin A stimulates glucose incorporation in the phosphatidylinositol 3-kinase (PI3K)- and Akt-dependent, but in the IR/IRS1-independent manner. |
|
67401-56-3 |
Micrococcin P1It is a thiopeptide antibiotic isolated from the culture broth of Bacillus pumilus as a main component of the micrococcin P complex. |
|
67700-30-5 |
R803R803 is a potent and highly specific HCV replication inhibitor with EC50s of about 30 nM for genotype 1a and 1b replicons, and an EC50 of about 1,000 nM for genotype 2a replicon. |
|
690270-29-2 |
BalapiravirBalapiravir is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase. It is the tri-isobutyrate ester prodrug of R1479 under clinical development to improve exposure of R1479 upon oral administration. It was discontinued for safety reasons in 28-36% of patients and the percentage of patients with serious adverse events was dose related. |
|
690270-65-6 |
Balapiravir hydrochlorideBalapiravir hydrochloride is an orally active prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp). It is an NS5B inhibitor that has the potential to treat HCV infection. |
|
691852-58-1 |
NesbuvirNesbuvir, a novel selective nonstructural protein 5B (NS5B) polymerase inhibitor, acts as candidate for HCV treatment. It was reduced across different isolates. |
|
691868-88-9 |
RO8191RO8191 is an agonist of interferon α receptor type 2 (IFNAR2) effective against HCV with EC50 value of 200 nM. RO8191 phosphorylates STAT1 and STAT2, which functions as a gateway to the type I IFN signal cascade, and stimulates the phosphorylation of STAT3, 5 and 6. |
|
78763-58-3 |
Deapio platycodin DDeapioplatycodin D is a triterpenoid saponin isolated from Platycodon grandiflorum, with anti-HCV activity. |
|
801283-95-4 |
FaldaprevirFaldaprevir, also called as BI 201335, is a potent, once-daily (QD), hepatitis C virus (HCV) NS3/4A protease inhibitor with the potential to treat HCV infection. Faldaprevir (BI 201335) is undergoing testing in a Phase II clinical study in Hepatitis C released by Trek Therapeutics. |
|
817204-33-4 |
PSI-6130PSI-6130 is a potent and selective inhibitor of HCV NS5B polymerase. It is metabolized to two pharmacologically active species in primary human hepatocytes. |
|
850876-88-9 |
DanoprevirDanoprevir(ITMN-191;R7227; RO5190591;RG7227) is a peptidomimetic inhibitor of the NS3/4A protease of hepatitis C virus (HCV) with IC50 of 0.2-3.5 nM, inhibition effect for HCV genotypes 1A/1B/4/5/6 is ~10-fold higher than 2B/3A. |
※ Please kindly note that our services are for research use only.